‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained

‘Immunocompromised Patients’ Response to COVID Vaccines – The OCTAVE study explained

Clare Jacklin, NRAS CEO in conversation with Professor Stefan Siebert of Glasgow University. The topic of discussion is to gain a better understanding of what the findings from the OCTAVE study tell us for those living with inflammatory arthritis. Recorded from an NRAS Facebook live session on 29 September 2021.